Social care staff twice as likely to die from Covid-19 – Nursing in Practice
The Covid-19 death rate among social care staff is two times higher than among the general population, while nurses have also suffered a higher death toll.
Related Articles
National booking system for spring Covid-19 vaccinations now open
The NHS national booking system for spring Covid-19 vaccination bookings via general practices is now open.
NHS England reviewing future of practitioner mental health service
NHS England’s mental health support service will no longer take on new secondary care workers, and will review its offer to all staff groups.
NHS England reviewing future of practitioner mental health service
NHS England’s mental health support service will no longer take on new secondary care workers, and will review its offer to all staff groups.
National booking system for spring Covid-19 vaccinations now open
The NHS national booking system for spring Covid-19 vaccination bookings via general practices is now open.
‘Unsustainable’: Survey reveals huge deficit for UK hospice sector
The UK hospice sector is facing a collective estimated deficit of £77m for the 2023/24 financial year, according to research by Hospice UK.
Scottish Government announces interim CNO
The Scottish Government has announced the appointment of an interim chief nursing officer (CNO) who will start in post later this month.
NHS England reviewing future of practitioner mental health service
NHS England’s mental health support service will no longer take on new secondary care workers, and will review its offer to all staff groups.
CPD: Rectal bleeding in adults – assessment and management in primary care
CPD eLearning module on what practice nurses need to consider when patients present with rectal bleeding
Supporting hypertension self-care: a nurse’s perspective
Nurse specialist advises on the crucial role nurses play in supporting patients with hypertension to understand and manage their condition
Diabetes drug shows potential in treating Parkinson’s disease
A medicine for type 2 diabetes may slow the progression of the symptoms of Parkinson’s disease, research has suggested.